Beximco Pharmaceuticals Ltd. has got approval from the Directorate General of Drug Administration (DGDA) to import the COVID-19 vaccine developed by the University of Oxford and AstraZeneca, reports BSS.
Ayub Hossain, the spokesperson of DGDA, told BSS tonight that the drug regulatory authority has given a No Objection Certificate (NOC) to Beximco Pharma to import the vaccine from Serum Institute of India.
At a press conference today, Health and Family Welfare Minister Zahid Maleque said Bangladesh will get COVID-19 vaccine doses in time as the country signed an agreement with the Serum Institute of India.
The press conference was held in the conference room of the Health and Family Welfare Ministry.
“Under the agreement, Bangladesh government will get three crore COVID-19 vaccine doses from the Serum Institute of India,” the health minister added.
On December 13, the agreement was signed for collecting three crore COVID-19 vaccine doses developed by the University of Oxford and AstraZeneca.
On November 5, a tripartite Memorandum of Understanding (MoU) was signed for collecting these three crore COVID-19 vaccine doses from the University of Oxford and AstraZeneca. The MoU was signed by the Bangladesh Government, Beximco Pharmaceuticals Ltd. (BPL), and the Serum Institute of India (SII).
The health ministry sources said 1.5 crore people will be administered by these three crore vaccine doses. As each person needs to be vaccinated twice they said, adding 50 lakh people in the country will be administered per month.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.